Increased expression of LAMTOR5 predicts poor prognosis and is associated with lymph node metastasis of head and neck squamous cell carcinoma

Late endosomal/lysosomal adaptor and MAPK and mTOR activator 5 (LAMTOR5) is a novel oncoprotein associated with several human malignancies, but its clinical role in head and neck squamous cell carcinoma (HNSCC) remains unclear.